| Deinococcaeota| Deinococcaeota Oren et al. 2015| Deinococcota| Deinococcus-Thermus| Thermus/Deinococcus group
Radiation resistance: Deinococcota bacteria, particularly species within the genus Deinococcus, are known for their remarkable resistance to ionizing radiation, UV radiation, desiccation, and other extreme environmental conditions. This resistance is due to their highly efficient DNA repair mechanisms, which enable them to survive exposure to high levels of radiation that would be lethal to most other organisms. While the radiation resistance of Deinococcota bacteria has important implications for their ecological roles and adaptation to extreme environments, it is not directly relevant to human health impacts.
Biotechnological applications: Deinococcota bacteria, especially Deinococcus radiodurans, have attracted interest for their potential biotechnological applications. Their robustness and ability to withstand harsh conditions make them promising candidates for various biotechnological processes, such as bioremediation of radioactive or contaminated environments, production of biofuels and bioplastics, and synthesis of valuable biomolecules. While these applications are primarily focused on environmental or industrial processes rather than direct human health impacts, they highlight the diverse metabolic capabilities and potential practical uses of Deinococcota bacteria.
Genomic stability: Deinococcota bacteria possess highly stable genomes, despite their exposure to DNA-damaging agents such as radiation. Understanding the mechanisms underlying genomic stability in Deinococcota bacteria has implications for genetic engineering, synthetic biology, and biomedicine. While these applications may have indirect benefits for human health, such as improved methods for gene editing and genetic engineering, they are not directly related to health impacts of Deinococcota bacteria on humans.
A lot more information is available when you are logged in and raise the display level
Other Sources for more information:
Statistics | NCBI | Data Punk | End Products Produced |
Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.
Lab | Frequency | UD-Low | UD-High | KM Low | KM High | Lab Low | Lab High | Mean | Median | Standard Deviation | Box Plot Low | Box Plot High | KM Percentile Low | KM Percentile High |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Labs | 2.12 | 10 | 93249 | 0 | 38604 | 6924.2 | 200 | 16163 | 0 | 16176 | 0 %ile | 100 %ile | ||
biomesight | 58.59 | 0 | 40 | 10 | 110 | 0 | 413 | 82.8 | 40 | 168.7 | 0 | 140 | 0 %ile | 90.7 %ile |
thorne | 100 | 16 | 254 | 0 | 241 | 105.5 | 77 | 69 | 43 | 167 | 0 %ile | 100 %ile | ||
thryve | 19.13 | 0 | 10 | 1 | 183 | 0 | 13490 | 623.8 | 22 | 6564.6 | 8 | 60 | 0 %ile | 95.8 %ile |
ubiome | 0.89 | 21 | 180 | 0 | 172 | 65.4 | 47 | 54.6 | 21 | 180 | 11.1 %ile | 77.8 %ile |
Source of Ranges | Low Boundary | High Boundary | Low Boundary %age | High Boundary %age |
---|---|---|---|---|
Thorne (20/80%ile) | 51.5 | 133.82 | 0.0052 | 0.0134 |
Lab | Frequency Seen | Average | Standard Deviation | Sample Count | Lab Samples |
---|---|---|---|---|---|
BiomeSight | 62.696 % | 0.009 % | 0.018 % | 1795.0 | 2863 |
BiomeSightRdp | 62.5 % | 0.061 % | 0.139 % | 20.0 | 32 |
bugspeak | 100 % | 0.02 % | % | 1.0 | 1 |
CerbaLab | 66.667 % | 0.003 % | 0.001 % | 2.0 | 3 |
custom | 1.695 % | 0.002 % | % | 1.0 | 59 |
es-xenogene | 17.241 % | 0.025 % | 0.02 % | 5.0 | 29 |
Medivere | 100 % | 2.723 % | 3.437 % | 7.0 | 7 |
SequentiaBiotech | 36.111 % | 0.996 % | 0.899 % | 13.0 | 36 |
Thorne | 85.227 % | 0.006 % | 0.006 % | 75.0 | 88 |
Thryve | 18.655 % | 0.052 % | 0.595 % | 258.0 | 1383 |
Tiny | 100 % | 0.001 % | % | 1.0 | 1 |
uBiome | 0.884 % | 0.007 % | 0.005 % | 7.0 | 792 |
Click on Impact for information if high or low levels are causing the impact
Magnitude | Impact | Symptom |
---|
|
And display level must be raised above public.
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.